Literature DB >> 11405064

Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the epithelial mucin (MUC1) on tissue sections of adenolymphomas of the parotid (Warthin's tumours): role of epitope masking by glycans.

Y Cao1, U Karsten.   

Abstract

Warthin's tumours provide a unique opportunity to distinguish and compare monoclonal antibodies (mAbs) to the epithelial mucin, MUC1. In this study, we have applied the range of anti-MUC1 antibodies submitted to the ISOBM TD-4 Workshop for this purpose. mAbs and lectins against MUC1-associated carbohydrate epitopes were also included. Among 39 mAbs to peptide epitopes of MUC1, eight distinct types of staining patterns towards the two epithelial cell layers of Warthin's tumours could be observed. A majority of 27 mAbs reacted preferentially (17) or exclusively (10) with columnar cells, whereas 10 mAbs favoured basal cells (1 of them almost exclusively). The observed staining patterns revealed no correlation with the epitopes. However, after carbohydrate-specific periodate oxidation, 33 of the mAbs stained columnar and basal cells equally well, indicating that epitope masking by glycan side chains was in most cases responsible for the different staining patterns. The results demonstrate the profound impact of glycosylation on immunohistochemistry. Among carbohydrate epitopes, sialyl-TF, sialyl-Le(x), sialyl-dimeric Le(x) and Tn were expressed on both columnar and basal cells (the s-TF3 isomer on columnar cells only). The carcinoma-associated Thomsen-Friedenreich epitope was absent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11405064     DOI: 10.1007/s004180100261

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  7 in total

Review 1.  Progress in focus: recent advances in histochemistry and cell biology.

Authors:  Esther Asan
Journal:  Histochem Cell Biol       Date:  2002-11-27       Impact factor: 4.304

2.  KL-6 mucin expression in carcinoma of the ampulla of Vater: association with cancer progression.

Authors:  Wei Tang; Yoshinori Inagaki; Norihiko Kokudo; Qian Guo; Yasuji Seyama; Munehiro Nakata; Hiroshi Imamura; Keiji Sano; Yasuhiko Sugawara; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

3.  Glycocalyx restricts adenoviral vector access to apical receptors expressed on respiratory epithelium in vitro and in vivo: role for tethered mucins as barriers to lumenal infection.

Authors:  Jaclyn R Stonebraker; Danielle Wagner; Robert W Lefensty; Kimberlie Burns; Sandra J Gendler; Jeffrey M Bergelson; Richard C Boucher; Wanda K O'Neal; Raymond J Pickles
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.

Authors:  Xiaoquan Wang; Natalia A Ilyushina; Vladimir Y Lugovtsev; Nicolai V Bovin; Laura K Couzens; Jin Gao; Raymond P Donnelly; Maryna C Eichelberger; Hongquan Wan
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

5.  Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.

Authors:  T Hamada; S Matsukita; M Goto; S Kitajima; S K Batra; T Irimura; K Sueyoshi; K Sugihara; S Yonezawa
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

6.  MUC1 aptamer-based near-infrared fluorescence probes for tumor imaging.

Authors:  Haiyan Chen; Juan Zhao; Min Zhang; Haibo Yang; Yuxiang Ma; Yueqing Gu
Journal:  Mol Imaging Biol       Date:  2015-02       Impact factor: 3.488

7.  Abnormally glycosylated MUC1 establishes a positive feedback circuit of inflammatory cytokines, mediated by NF-κB p65 and EzH2, in colitis-associated cancer.

Authors:  Sandra Cascio; Jacque L Faylo; Joshua C Sciurba; Jia Xue; Sarangarajan Ranganathan; Jason J Lohmueller; Pamela L Beatty; Olivera J Finn
Journal:  Oncotarget       Date:  2017-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.